Group One Trading
ENVB icon

Group One Trading’s Enveric Biosciences ENVB Stock Holding History

Group One Trading’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Hold
1
– – ﹤0.01% 7484
2025
Q4 		$4 Buy
+1
New +$7 ﹤0.01% 7968
2025
Q3 		– Hold
0
– – – 8294
2025
Q2 		– Sell
-2
Closed -$30 – 7842
2025
Q1 		$26 Hold
2
– – ﹤0.01% 7440
2024
Q4 		$98 Hold
2
– – ﹤0.01% 7100
2024
Q3 		$129 Hold
2
– – ﹤0.01% 6469
2024
Q2 		$169 Hold
2
– – ﹤0.01% 6524
2024
Q1 		$273 Hold
2
– – ﹤0.01% 6789
2023
Q4 		$355 Hold
2
– – ﹤0.01% 7123
2023
Q3 		$631 Hold
2
– – ﹤0.01% 7299
2023
Q2 		$920 Hold
2
– – ﹤0.01% 7275
2023
Q1 		$459 Hold
2
– – ﹤0.01% 6917
2022
Q4 		$560 Sell
2
-5
-71% -$2.77K ﹤0.01% 6930
2022
Q3 		$5K Hold
7
– – ﹤0.01% 6823
2022
Q2 		$13K Buy
7
+1
+17% +$2.13K ﹤0.01% 6603
2022
Q1 		$17K Hold
6
– – ﹤0.01% 6856
2021
Q4 		$49K Buy
+6
New +$84.3K ﹤0.01% 6353

Other funds holding ENVB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's ENVB Position: Q1 2026 in Review

Group One Trading held its Enveric Biosciences (ENVB) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7484.

Group One Trading first reported a position in ENVB in Q4 2021 and has held it in 16 quarters since. The position peaked at $49K in Q4 2021. 11 funds tracked by Wall St. Rank hold ENVB as of Q1 2026.

  • Group One Trading held 1 share of Enveric Biosciences worth $2 as of Q1 2026.
  • Group One Trading left its Enveric Biosciences share count unchanged in Q1 2026.
  • Enveric Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7484 holding.
  • Group One Trading first reported a position in Enveric Biosciences in Q4 2021 and has held it in 16 quarters since.
  • Group One Trading's Enveric Biosciences position peaked at $49K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Enveric Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.